Work Here?
Arkana Laboratories
Work Here?
Clinicopathologic consultations to improve patient care
Arkana Laboratories
Work Here?
Clinicopathologic consultations to improve patient care
Overview
Arkana Laboratories provides specialized pathology services with a focus on esoteric pathology to support patient care. Their offerings center on high-quality clinicopathologic discussions and close collaboration with clinicians, treating the lab as an extension of a doctor’s practice to help deliver timely, accurate biopsy interpretations. Their approach emphasizes fast, clear communication of results and expert interpretation to guide patient treatment. Unlike typical labs, Arkana positions itself as a partner in care, prioritizing the clinician’s needs and the patient’s outcome over volume. The company’s goal is to shorten the time from biopsy to result and equip doctors with precise information to deliver the most effective care.
About Arkana Laboratories
Industries
Data & Analytics
Consulting
AI & Machine Learning
Biotechnology
Healthcare
Company Size
51-200
Company Stage
Grant
Total Funding
$2.8M
Headquarters
Little Rock, Arkansas
Founded
2001
Get referred to Arkana Laboratories
See people who can refer or advise you
Simplify's Take
What believers are saying
- The May 2026 expansion added 24,000 square feet and modernized operations.
- NIH awarded $266,613 in 2026 to advance a rapid transplant rejection test.
- Published 2026 work on APOL1, membranous nephropathy, and biopsy prediction keeps scientific credibility high.
What critics are saying
- Indeed reviews through July 2026 cite micromanagement, bad communication, and low appreciation.
- Arkana’s niche kidney-biopsy demand depends on transplant volumes and reimbursement decisions.
- If the rejection test misses Phase II validation, growth stalls and differentiation weakens.
What makes Arkana Laboratories unique
- Arkana celebrated a $24 million renovated Little Rock lab on May 7, 2026.
- It offers same-day biopsy service nationwide, rare among specialty renal pathology labs.
- Its 25-year publication record and NIH-funded rejection test reinforce scientific depth.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$2.8M
Above
Industry Average
Funded Over
2 Rounds
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Health Savings Account/Flexible Spending Account
Unlimited Paid Time Off
Paid Vacation
Paid Holidays
Hybrid Work Options
401(k) Retirement Plan
401(k) Company Match
Wellness Program
Mental Health Support
Growth & Insights and Company News
6 month growth
↓ -1%1 year growth
↓ -1%2 year growth
↑ 0%Arkana Laboratories has received a $266,613 Phase I Small Business Innovation Research grant from the National Institutes of Health to develop a diagnostic test for kidney transplant patients experiencing rejection. The one-year project, funded by the National Institute of Allergy and Infectious Diseases, aims to predict treatment resistance in T-cell mediated rejection cases at the time of diagnosis. Currently, physicians cannot reliably determine which patients will respond to standard treatment, which fails in approximately 30–50% of cases. The team previously identified a 27-gene pattern that can predict treatment response. This Phase I award will fund development of a rapid qPCR-based test to measure this signature using kidney biopsy tissue, with results available within a single day. Dr Chris Larsen will serve as principal investigator, with Owen Stephens as co-investigator. If successful, the team plans to pursue Phase II funding to validate the test for clinical use.
Early in 2025, Arkana, a new cybercriminal organization, emerged and boldly claimed to have stolen over two million customer records from a significant internet provider in the United States.
Little Rock, Arkansas — According to state and local economic development sources Arkana Laboratories plans to invest $30,000,000.00 to build out 10,000 square feet of new space in Little Rock. The company plans to occupy the new space at 10810 Executive Center Dr #100 in Little Rock, on or about January 1, 2024. According to the company website Arkana Laboratories is a center for esoteric pathology focused on one thing: improving care for patients. Arkana is committed to providing doctors with the highest quality, clinicopathologic discussion possible. We recognize that in order to best serve the needs of our clinicians we must work together with them, not just as a lab, but as an extension of their practice. It is our goal to help equip doctors with the results they need to deliver the most effective patient care possible. As pathologists, we recognize that the longest period in a patients life is the timeframe between the day he/she has a biopsy and the day the result arrives. To learn more about Arkana Laboratories, visit http://www.arkanalabs.com/
Plans call for more than 70 new jobs and a 10,000-SF addition to its facility.
(Courtesy photo, Arkansas governor's office) Arkana Laboratories will invest upwards of $30 million to expand its Little Rock headquarters and add 74 new jobs in the next five years.
Arkana Laboratories is Hiring for 12 Jobs on Simplify!
Find jobs on Simplify and start your career today
About Arkana Laboratories
Industries
Data & Analytics
Consulting
AI & Machine Learning
Biotechnology
Healthcare
Company Size
51-200
Company Stage
Grant
Total Funding
$2.8M
Headquarters
Little Rock, Arkansas
Founded
2001
Arkana Laboratories is Hiring for 12 Jobs on Simplify!
Find jobs on Simplify and start your career today